Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RNF219 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SUCLG1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | MED23 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PTPRA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TBC1D10C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | NDUFAF6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ARHGDIB | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
mRNA | ZNF629 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | LRRK2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NUCB2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |